CNS PHARMACEUTICALS INC (CNSP)

US18978H2013 - Common Stock

0.2249  +0.03 (+12.68%)

After market: 0.222 0 (-1.29%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
548.72K10.06M5.00M14.04M7.24M
Other Current Assets
1.04M2.51M2.47M1.46M650.00K
Total Current Assets
1.59M12.56M7.48M15.50M7.89M
 
Non-Current Assets
PPE Net
4.93K10.00K20.00K20.00K20.00K
Other Non-Current Assets
104.75K480.00K1.26M330.00K0.00
Total Non-Current Assets
109.68K490.00K1.28M350.00K20.00K
 
TOTAL ASSETS
1.70M13.05M8.76M15.85M7.91M
 
LIABILITIES
Current Liabilities
Short Term Debt
300.81K410.00K390.00K440.00K0.00
Accrued Expenses
N/A830.00K220.00K520.00K20.00K
Accounts Payable
5.83M3.68M1.98M950.00K290.00K
Other Current Liabilities
N/AN/AN/AN/A0.00
Total Current Liabilities
6.13M4.92M2.59M1.91M310.00K
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Total Non-Current Liabilities
0.000.000.000.000.00
 
TOTAL LIABILITIES
6.13M4.92M2.59M1.91M310.00K
 
SHAREHOLDERS' EQUITY
Retained Earnings
-69.57M-50.72M-35.44M-20.95M-11.49M
Additional Paid In Capital
65.13M58.85M41.60M34.87M19.07M
Common Shares
6.21K0.000.0020.00K20.00K
Shares Outstanding
6.21M1.62M950.00K800.00K550.00K
Tangible Book Value per Share
-0.715.026.4817.4413.82
Total Shareholders' Equity
-4.43M8.13M6.16M13.95M7.60M
 
TOTAL LIABILITIES AND EQUITY
1.70M13.05M8.76M15.85M7.91M
 
Statistics
Current Ratio
0.262.552.898.1225.45
Return On Assets (ROA)
-1108.34%-117.01%-165.53%-59.68%-49.05%
Return On Equity (ROE)
N/A-187.82%-235.39%-67.81%-51.05%

All data in USD

Charts